Rami Z. Morsi: Advancing the Full Spectrum of Stroke Care at UCM 2026 3rd Annual Stroke Symposium
Rami Z. Morsi, NIH StrokeNet Fellow at UChicago Medicine, shared a post on LinkedIn:
“Honored to take part in the University of Chicago Department of Neurology Neurosurgery UCM 2026 3rd Annual Stroke Symposium, where a packed room of neurologists, neurosurgeons, emergency physicians, and trainees spent the day stress-testing how we diagnose, treat, and prevent stroke.
The program spanned the full continuum of stroke care: acute reperfusion, secondary prevention, hemorrhage management, and systems-level care.
Highlights included:
- Dr. Shyam Prabhakaran on translating AHA/ASA acute ischemic stroke guidelines into real-world decision-making
- Dr. Sean Polster on minimally invasive surgery for intracerebral hemorrhage and when it can shift the trajectory for patients
- Dr. Ryan Naylor on endovascular thrombectomy for medium and distal vessel occlusions and how far we can safely push the boundaries
- Dr. Fernando Goldenberg on building and running an effective Code ICH
- Dr. James Siegler on lipid-lowering therapy and what ‘aggressive’ really means in 2026
- Dr. Matthew Smith on falls, frailty, and how we think about intracranial bleeding risk in everyday practice
- Dr. Shadi Yaghi on cervical artery dissections and tailoring management to the individual patient
- Dr. Tareq Kass-Hout on intra-arterial stenting and evolving endovascular strategies
- Dr. Michael Hurley on carotid webs, an under-recognized cause of stroke
- A fiery but collegial debate between Dr. Richa Sharma and me on antiplatelet versus anticoagulation for LV dysfunction
And this was just a sample of the discussions.
There were many other high-yield sessions that made the day feel both humbling and energizing.
Grateful to the organizers and course directors for bringing together such a thoughtful, multidisciplinary group and for creating a space where people felt comfortable challenging dogma and focusing on what matters most:
better outcomes for patients and families.”

Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering